Global Artificial Intelligence in Drug Discovery

Artificial Intelligence in Drug Discovery Comprehensive Study by Application (Disease Identification/Diagnosis, Digital Therapeutics / Personalized Treatment/Behavioral Modification, Drug Discovery and Manufacturing, Predictive Forecasting, Clinical Trials), Therapeutic area (Immuno-Oncology, Neurodegenerative Diseases, Cardiovascular Diseases, Others), Functionality (Generating novel drug candidates, Understanding disease mechanisms, Aggregating and synthesizing information), Offering (Software, Services), End User (Pharmaceutical & Biotechnology Companies, Contract Research Organizations, Research Centers, Academic & Government Institutes) Players and Region - Global Market Outlook to 2028

Artificial Intelligence in Drug Discovery Market by XX Submarkets | Forecast Years 2023-2028  

Access Sample Report Make An Enquiry Before Purchase
  • Summary
  • Market Segments
  • Table of Content
  • List of Table & Figures
  • Players Profiled
What is Artificial Intelligence in Drug Discovery Market?

Machine learning and AI have been assuming a critical role in the drug business and customer medical services business, Artificial Intelligence (AI), particularly profound learning and AI, is coming out as problematic innovation for the quicker revelation and improvement of innovative therapies. There is a ton of excitement about the opportunities related to the use of Artificial Intelligence. To overcome the limitations the traditional drug discovery methods are facing due to the complex nature of cellular interactions as well as limited knowledge of intricate cellular pathways the artificial intelligence in drug discovery is utilized, it beats the difficulties by recognizing novel communications and deriving the functional importance of the various segments of a cell pathway and other issues as well. Artificial Intelligence uses the most recent advances in science and processing to create cutting edge calculations for drug discovery. With the fast expansion in the preparing force and decrease in handling cost, AI can possibly make everything fair in drug improvement.

Highlights from Artificial Intelligence in Drug Discovery Market Study
AttributesDetails
Study Period2018-2028
Base Year2022
UnitValue (USD Million)
Key Companies ProfiledIBM Corporation (United States), Microsoft Corporation (United States), Google LLC (United States), NVIDIA Corporation (United States), Atomwise, Inc. (United States), Deep Genomics (Canada), Cloud Pharmaceuticals, Inc. (United States), Insilico Medicine (United States), BenevolentAI Limited (United Kingdom) and Exscientia Limited (United Kingdom)


The companies are exploring the market by adopting mergers & acquisitions, expansions, investments, new service launches, and collaborations as their preferred strategies. The players are exploring new geographies through expansions and acquisitions to avail a competitive advantage through combined synergies. Research Analyst at AMA predicts that United States Players will contribute to the maximum growth of Global Artificial Intelligence in Drug Discovery market throughout the forecasted period.

IBM Corporation (United States), Microsoft Corporation (United States), Google LLC (United States), NVIDIA Corporation (United States), Atomwise, Inc. (United States), Deep Genomics (Canada), Cloud Pharmaceuticals, Inc. (United States), Insilico Medicine (United States), BenevolentAI Limited (United Kingdom) and Exscientia Limited (United Kingdom) are some of the key players profiled in the study.

Artificial Intelligence in Drug Discovery Market Segmentation:
ScopeSub-Segments
Application / End UserDisease Identification/Diagnosis, Digital Therapeutics / Personalized Treatment/Behavioral Modification, Drug Discovery and Manufacturing, Predictive Forecasting and Clinical Trials
Therapeutic areaImmuno-Oncology,Neurodegenerative Diseases,Cardiovascular Diseases,Others
FunctionalityGenerating novel drug candidates,Understanding disease mechanisms,Aggregating and synthesizing information
OfferingSoftware,Services
End UserPharmaceutical & Biotechnology Companies,Contract Research Organizations,Research Centers,Academic & Government Institutes


On the basis of geography, the market of Artificial Intelligence in Drug Discovery has been segmented into South America (Brazil, Argentina, Rest of South America), Asia Pacific (China, Japan, India, South Korea, Taiwan, Australia, Rest of Asia-Pacific), Europe (Germany, France, Italy, United Kingdom, Netherlands, Rest of Europe), MEA (Middle East, Africa), North America (United States, Canada, Mexico). Additionally, the rising demand from SMEs and various industry verticals gives enough cushion to market growth.

Influencing Trend:
The involvement of several startups are using AI to improve the process of drug discovery and development

Market Growth Drivers:
The surge in cross-industry collaborations and partnerships to boost drug discovery drives the growth of the global artificial intelligence for the drug discovery and development market and Growing awareness related to artificial intelligence is expected to provide new opportunities for market players in near future.

Challenges:
Lack of AI specialists and Inconsistency in the regulatory framework and ethical issues related to the usage of AI are the major barriers

Restraints:
The biggest restraints of using AI to predict medication targets remains translating traditional basic research conducted in labs around the world into a language that a computer can understand.

Opportunities:
Technological Advancements with Introduction of AI in Drug Discovery

Key Target Audience
New Entrants/Investors, Analysts and Strategic Business Planners, Artificial Intelligence in Drug Discovery Providers, Government Regulatory and Research Organizations and End-Use Industry

Market Leaders & Development Strategies
In September 2022, Novo Nordisk partnered with Microsoft for AI-driven drug discovery. AI leveraged for detecting new targets and validating disease biomarkers under the partnership.
In January 2021 MedAI United States based firm has Launches Artificial Intelligence Drug Discovery (AIDD) Platform to Accelerate Drug Development. The company announces that it has completed the construction of its Artificial Intelligence Drug Discovery (AIDD) Platform. With the use of this platform, the scientist can be able to provide innovative solutions for pharmaceutical companies to push ahead with their drug discovery projects.


Report Objectives / Segmentation Covered

By Application
  • Disease Identification/Diagnosis
  • Digital Therapeutics / Personalized Treatment/Behavioral Modification
  • Drug Discovery and Manufacturing
  • Predictive Forecasting
  • Clinical Trials
By Therapeutic area
  • Immuno-Oncology
  • Neurodegenerative Diseases
  • Cardiovascular Diseases
  • Others

By Functionality
  • Generating novel drug candidates
  • Understanding disease mechanisms
  • Aggregating and synthesizing information

By Offering
  • Software
  • Services

By End User
  • Pharmaceutical & Biotechnology Companies
  • Contract Research Organizations
  • Research Centers
  • Academic & Government Institutes

By Regions
  • South America
    • Brazil
    • Argentina
    • Rest of South America
  • Asia Pacific
    • China
    • Japan
    • India
    • South Korea
    • Taiwan
    • Australia
    • Rest of Asia-Pacific
  • Europe
    • Germany
    • France
    • Italy
    • United Kingdom
    • Netherlands
    • Rest of Europe
  • MEA
    • Middle East
    • Africa
  • North America
    • United States
    • Canada
    • Mexico
  • 1. Market Overview
    • 1.1. Introduction
    • 1.2. Scope/Objective of the Study
      • 1.2.1. Research Objective
  • 2. Executive Summary
    • 2.1. Introduction
  • 3. Market Dynamics
    • 3.1. Introduction
    • 3.2. Market Drivers
      • 3.2.1. The surge in cross-industry collaborations and partnerships to boost drug discovery drives the growth of the global artificial intelligence for the drug discovery and development market
      • 3.2.2. Growing awareness related to artificial intelligence is expected to provide new opportunities for market players in near future.
    • 3.3. Market Challenges
      • 3.3.1. Lack of AI specialists
      • 3.3.2. Inconsistency in the regulatory framework and ethical issues related to the usage of AI are the major barriers
    • 3.4. Market Trends
      • 3.4.1. The involvement of several startups are using AI to improve the process of drug discovery and development
  • 4. Market Factor Analysis
    • 4.1. Porters Five Forces
    • 4.2. Supply/Value Chain
    • 4.3. PESTEL analysis
    • 4.4. Market Entropy
    • 4.5. Patent/Trademark Analysis
  • 5. Global Artificial Intelligence in Drug Discovery, by Application, Therapeutic area, Functionality, Offering, End User and Region (value) (2017-2022)
    • 5.1. Introduction
    • 5.2. Global Artificial Intelligence in Drug Discovery (Value)
      • 5.2.1. Global Artificial Intelligence in Drug Discovery by: Application (Value)
        • 5.2.1.1. Disease Identification/Diagnosis
        • 5.2.1.2. Digital Therapeutics / Personalized Treatment/Behavioral Modification
        • 5.2.1.3. Drug Discovery and Manufacturing
        • 5.2.1.4. Predictive Forecasting
        • 5.2.1.5. Clinical Trials
      • 5.2.2. Global Artificial Intelligence in Drug Discovery by: Therapeutic area (Value)
        • 5.2.2.1. Immuno-Oncology
        • 5.2.2.2. Neurodegenerative Diseases
        • 5.2.2.3. Cardiovascular Diseases
        • 5.2.2.4. Others
      • 5.2.3. Global Artificial Intelligence in Drug Discovery by: Functionality (Value)
        • 5.2.3.1. Generating novel drug candidates
        • 5.2.3.2. Understanding disease mechanisms
        • 5.2.3.3. Aggregating and synthesizing information
      • 5.2.4. Global Artificial Intelligence in Drug Discovery by: Offering (Value)
        • 5.2.4.1. Software
        • 5.2.4.2. Services
      • 5.2.5. Global Artificial Intelligence in Drug Discovery by: End User (Value)
        • 5.2.5.1. Pharmaceutical & Biotechnology Companies
        • 5.2.5.2. Contract Research Organizations
        • 5.2.5.3. Research Centers
        • 5.2.5.4. Academic & Government Institutes
      • 5.2.6. Global Artificial Intelligence in Drug Discovery Region
        • 5.2.6.1. South America
          • 5.2.6.1.1. Brazil
          • 5.2.6.1.2. Argentina
          • 5.2.6.1.3. Rest of South America
        • 5.2.6.2. Asia Pacific
          • 5.2.6.2.1. China
          • 5.2.6.2.2. Japan
          • 5.2.6.2.3. India
          • 5.2.6.2.4. South Korea
          • 5.2.6.2.5. Taiwan
          • 5.2.6.2.6. Australia
          • 5.2.6.2.7. Rest of Asia-Pacific
        • 5.2.6.3. Europe
          • 5.2.6.3.1. Germany
          • 5.2.6.3.2. France
          • 5.2.6.3.3. Italy
          • 5.2.6.3.4. United Kingdom
          • 5.2.6.3.5. Netherlands
          • 5.2.6.3.6. Rest of Europe
        • 5.2.6.4. MEA
          • 5.2.6.4.1. Middle East
          • 5.2.6.4.2. Africa
        • 5.2.6.5. North America
          • 5.2.6.5.1. United States
          • 5.2.6.5.2. Canada
          • 5.2.6.5.3. Mexico
  • 6. Artificial Intelligence in Drug Discovery: Manufacturers/Players Analysis
    • 6.1. Competitive Landscape
      • 6.1.1. Market Share Analysis
        • 6.1.1.1. Top 3
        • 6.1.1.2. Top 5
    • 6.2. Peer Group Analysis (2022)
    • 6.3. BCG Matrix
    • 6.4. Company Profile
      • 6.4.1. IBM Corporation (United States)
        • 6.4.1.1. Business Overview
        • 6.4.1.2. Products/Services Offerings
        • 6.4.1.3. Financial Analysis
        • 6.4.1.4. SWOT Analysis
      • 6.4.2. Microsoft Corporation (United States)
        • 6.4.2.1. Business Overview
        • 6.4.2.2. Products/Services Offerings
        • 6.4.2.3. Financial Analysis
        • 6.4.2.4. SWOT Analysis
      • 6.4.3. Google LLC (United States)
        • 6.4.3.1. Business Overview
        • 6.4.3.2. Products/Services Offerings
        • 6.4.3.3. Financial Analysis
        • 6.4.3.4. SWOT Analysis
      • 6.4.4. NVIDIA Corporation (United States)
        • 6.4.4.1. Business Overview
        • 6.4.4.2. Products/Services Offerings
        • 6.4.4.3. Financial Analysis
        • 6.4.4.4. SWOT Analysis
      • 6.4.5. Atomwise, Inc. (United States)
        • 6.4.5.1. Business Overview
        • 6.4.5.2. Products/Services Offerings
        • 6.4.5.3. Financial Analysis
        • 6.4.5.4. SWOT Analysis
      • 6.4.6. Deep Genomics (Canada)
        • 6.4.6.1. Business Overview
        • 6.4.6.2. Products/Services Offerings
        • 6.4.6.3. Financial Analysis
        • 6.4.6.4. SWOT Analysis
      • 6.4.7. Cloud Pharmaceuticals, Inc. (United States)
        • 6.4.7.1. Business Overview
        • 6.4.7.2. Products/Services Offerings
        • 6.4.7.3. Financial Analysis
        • 6.4.7.4. SWOT Analysis
      • 6.4.8. Insilico Medicine (United States)
        • 6.4.8.1. Business Overview
        • 6.4.8.2. Products/Services Offerings
        • 6.4.8.3. Financial Analysis
        • 6.4.8.4. SWOT Analysis
      • 6.4.9. BenevolentAI Limited (United Kingdom)
        • 6.4.9.1. Business Overview
        • 6.4.9.2. Products/Services Offerings
        • 6.4.9.3. Financial Analysis
        • 6.4.9.4. SWOT Analysis
      • 6.4.10. Exscientia Limited (United Kingdom)
        • 6.4.10.1. Business Overview
        • 6.4.10.2. Products/Services Offerings
        • 6.4.10.3. Financial Analysis
        • 6.4.10.4. SWOT Analysis
  • 7. Global Artificial Intelligence in Drug Discovery Sale, by Application, Therapeutic area, Functionality, Offering, End User and Region (value) (2023-2028)
    • 7.1. Introduction
    • 7.2. Global Artificial Intelligence in Drug Discovery (Value)
      • 7.2.1. Global Artificial Intelligence in Drug Discovery by: Application (Value)
        • 7.2.1.1. Disease Identification/Diagnosis
        • 7.2.1.2. Digital Therapeutics / Personalized Treatment/Behavioral Modification
        • 7.2.1.3. Drug Discovery and Manufacturing
        • 7.2.1.4. Predictive Forecasting
        • 7.2.1.5. Clinical Trials
      • 7.2.2. Global Artificial Intelligence in Drug Discovery by: Therapeutic area (Value)
        • 7.2.2.1. Immuno-Oncology
        • 7.2.2.2. Neurodegenerative Diseases
        • 7.2.2.3. Cardiovascular Diseases
        • 7.2.2.4. Others
      • 7.2.3. Global Artificial Intelligence in Drug Discovery by: Functionality (Value)
        • 7.2.3.1. Generating novel drug candidates
        • 7.2.3.2. Understanding disease mechanisms
        • 7.2.3.3. Aggregating and synthesizing information
      • 7.2.4. Global Artificial Intelligence in Drug Discovery by: Offering (Value)
        • 7.2.4.1. Software
        • 7.2.4.2. Services
      • 7.2.5. Global Artificial Intelligence in Drug Discovery by: End User (Value)
        • 7.2.5.1. Pharmaceutical & Biotechnology Companies
        • 7.2.5.2. Contract Research Organizations
        • 7.2.5.3. Research Centers
        • 7.2.5.4. Academic & Government Institutes
      • 7.2.6. Global Artificial Intelligence in Drug Discovery Region
        • 7.2.6.1. South America
          • 7.2.6.1.1. Brazil
          • 7.2.6.1.2. Argentina
          • 7.2.6.1.3. Rest of South America
        • 7.2.6.2. Asia Pacific
          • 7.2.6.2.1. China
          • 7.2.6.2.2. Japan
          • 7.2.6.2.3. India
          • 7.2.6.2.4. South Korea
          • 7.2.6.2.5. Taiwan
          • 7.2.6.2.6. Australia
          • 7.2.6.2.7. Rest of Asia-Pacific
        • 7.2.6.3. Europe
          • 7.2.6.3.1. Germany
          • 7.2.6.3.2. France
          • 7.2.6.3.3. Italy
          • 7.2.6.3.4. United Kingdom
          • 7.2.6.3.5. Netherlands
          • 7.2.6.3.6. Rest of Europe
        • 7.2.6.4. MEA
          • 7.2.6.4.1. Middle East
          • 7.2.6.4.2. Africa
        • 7.2.6.5. North America
          • 7.2.6.5.1. United States
          • 7.2.6.5.2. Canada
          • 7.2.6.5.3. Mexico
  • 8. Appendix
    • 8.1. Acronyms
  • 9. Methodology and Data Source
    • 9.1. Methodology/Research Approach
      • 9.1.1. Research Programs/Design
      • 9.1.2. Market Size Estimation
      • 9.1.3. Market Breakdown and Data Triangulation
    • 9.2. Data Source
      • 9.2.1. Secondary Sources
      • 9.2.2. Primary Sources
    • 9.3. Disclaimer
List of Tables
  • Table 1. Artificial Intelligence in Drug Discovery: by Application(USD Million)
  • Table 2. Artificial Intelligence in Drug Discovery Disease Identification/Diagnosis , by Region USD Million (2017-2022)
  • Table 3. Artificial Intelligence in Drug Discovery Digital Therapeutics / Personalized Treatment/Behavioral Modification , by Region USD Million (2017-2022)
  • Table 4. Artificial Intelligence in Drug Discovery Drug Discovery and Manufacturing , by Region USD Million (2017-2022)
  • Table 5. Artificial Intelligence in Drug Discovery Predictive Forecasting , by Region USD Million (2017-2022)
  • Table 6. Artificial Intelligence in Drug Discovery Clinical Trials , by Region USD Million (2017-2022)
  • Table 7. Artificial Intelligence in Drug Discovery: by Therapeutic area(USD Million)
  • Table 8. Artificial Intelligence in Drug Discovery Immuno-Oncology , by Region USD Million (2017-2022)
  • Table 9. Artificial Intelligence in Drug Discovery Neurodegenerative Diseases , by Region USD Million (2017-2022)
  • Table 10. Artificial Intelligence in Drug Discovery Cardiovascular Diseases , by Region USD Million (2017-2022)
  • Table 11. Artificial Intelligence in Drug Discovery Others , by Region USD Million (2017-2022)
  • Table 12. Artificial Intelligence in Drug Discovery: by Functionality(USD Million)
  • Table 13. Artificial Intelligence in Drug Discovery Generating novel drug candidates , by Region USD Million (2017-2022)
  • Table 14. Artificial Intelligence in Drug Discovery Understanding disease mechanisms , by Region USD Million (2017-2022)
  • Table 15. Artificial Intelligence in Drug Discovery Aggregating and synthesizing information , by Region USD Million (2017-2022)
  • Table 16. Artificial Intelligence in Drug Discovery: by Offering(USD Million)
  • Table 17. Artificial Intelligence in Drug Discovery Software , by Region USD Million (2017-2022)
  • Table 18. Artificial Intelligence in Drug Discovery Services , by Region USD Million (2017-2022)
  • Table 19. Artificial Intelligence in Drug Discovery: by End User(USD Million)
  • Table 20. Artificial Intelligence in Drug Discovery Pharmaceutical & Biotechnology Companies , by Region USD Million (2017-2022)
  • Table 21. Artificial Intelligence in Drug Discovery Contract Research Organizations , by Region USD Million (2017-2022)
  • Table 22. Artificial Intelligence in Drug Discovery Research Centers , by Region USD Million (2017-2022)
  • Table 23. Artificial Intelligence in Drug Discovery Academic & Government Institutes , by Region USD Million (2017-2022)
  • Table 24. South America Artificial Intelligence in Drug Discovery, by Country USD Million (2017-2022)
  • Table 25. South America Artificial Intelligence in Drug Discovery, by Application USD Million (2017-2022)
  • Table 26. South America Artificial Intelligence in Drug Discovery, by Therapeutic area USD Million (2017-2022)
  • Table 27. South America Artificial Intelligence in Drug Discovery, by Functionality USD Million (2017-2022)
  • Table 28. South America Artificial Intelligence in Drug Discovery, by Offering USD Million (2017-2022)
  • Table 29. South America Artificial Intelligence in Drug Discovery, by End User USD Million (2017-2022)
  • Table 30. Brazil Artificial Intelligence in Drug Discovery, by Application USD Million (2017-2022)
  • Table 31. Brazil Artificial Intelligence in Drug Discovery, by Therapeutic area USD Million (2017-2022)
  • Table 32. Brazil Artificial Intelligence in Drug Discovery, by Functionality USD Million (2017-2022)
  • Table 33. Brazil Artificial Intelligence in Drug Discovery, by Offering USD Million (2017-2022)
  • Table 34. Brazil Artificial Intelligence in Drug Discovery, by End User USD Million (2017-2022)
  • Table 35. Argentina Artificial Intelligence in Drug Discovery, by Application USD Million (2017-2022)
  • Table 36. Argentina Artificial Intelligence in Drug Discovery, by Therapeutic area USD Million (2017-2022)
  • Table 37. Argentina Artificial Intelligence in Drug Discovery, by Functionality USD Million (2017-2022)
  • Table 38. Argentina Artificial Intelligence in Drug Discovery, by Offering USD Million (2017-2022)
  • Table 39. Argentina Artificial Intelligence in Drug Discovery, by End User USD Million (2017-2022)
  • Table 40. Rest of South America Artificial Intelligence in Drug Discovery, by Application USD Million (2017-2022)
  • Table 41. Rest of South America Artificial Intelligence in Drug Discovery, by Therapeutic area USD Million (2017-2022)
  • Table 42. Rest of South America Artificial Intelligence in Drug Discovery, by Functionality USD Million (2017-2022)
  • Table 43. Rest of South America Artificial Intelligence in Drug Discovery, by Offering USD Million (2017-2022)
  • Table 44. Rest of South America Artificial Intelligence in Drug Discovery, by End User USD Million (2017-2022)
  • Table 45. Asia Pacific Artificial Intelligence in Drug Discovery, by Country USD Million (2017-2022)
  • Table 46. Asia Pacific Artificial Intelligence in Drug Discovery, by Application USD Million (2017-2022)
  • Table 47. Asia Pacific Artificial Intelligence in Drug Discovery, by Therapeutic area USD Million (2017-2022)
  • Table 48. Asia Pacific Artificial Intelligence in Drug Discovery, by Functionality USD Million (2017-2022)
  • Table 49. Asia Pacific Artificial Intelligence in Drug Discovery, by Offering USD Million (2017-2022)
  • Table 50. Asia Pacific Artificial Intelligence in Drug Discovery, by End User USD Million (2017-2022)
  • Table 51. China Artificial Intelligence in Drug Discovery, by Application USD Million (2017-2022)
  • Table 52. China Artificial Intelligence in Drug Discovery, by Therapeutic area USD Million (2017-2022)
  • Table 53. China Artificial Intelligence in Drug Discovery, by Functionality USD Million (2017-2022)
  • Table 54. China Artificial Intelligence in Drug Discovery, by Offering USD Million (2017-2022)
  • Table 55. China Artificial Intelligence in Drug Discovery, by End User USD Million (2017-2022)
  • Table 56. Japan Artificial Intelligence in Drug Discovery, by Application USD Million (2017-2022)
  • Table 57. Japan Artificial Intelligence in Drug Discovery, by Therapeutic area USD Million (2017-2022)
  • Table 58. Japan Artificial Intelligence in Drug Discovery, by Functionality USD Million (2017-2022)
  • Table 59. Japan Artificial Intelligence in Drug Discovery, by Offering USD Million (2017-2022)
  • Table 60. Japan Artificial Intelligence in Drug Discovery, by End User USD Million (2017-2022)
  • Table 61. India Artificial Intelligence in Drug Discovery, by Application USD Million (2017-2022)
  • Table 62. India Artificial Intelligence in Drug Discovery, by Therapeutic area USD Million (2017-2022)
  • Table 63. India Artificial Intelligence in Drug Discovery, by Functionality USD Million (2017-2022)
  • Table 64. India Artificial Intelligence in Drug Discovery, by Offering USD Million (2017-2022)
  • Table 65. India Artificial Intelligence in Drug Discovery, by End User USD Million (2017-2022)
  • Table 66. South Korea Artificial Intelligence in Drug Discovery, by Application USD Million (2017-2022)
  • Table 67. South Korea Artificial Intelligence in Drug Discovery, by Therapeutic area USD Million (2017-2022)
  • Table 68. South Korea Artificial Intelligence in Drug Discovery, by Functionality USD Million (2017-2022)
  • Table 69. South Korea Artificial Intelligence in Drug Discovery, by Offering USD Million (2017-2022)
  • Table 70. South Korea Artificial Intelligence in Drug Discovery, by End User USD Million (2017-2022)
  • Table 71. Taiwan Artificial Intelligence in Drug Discovery, by Application USD Million (2017-2022)
  • Table 72. Taiwan Artificial Intelligence in Drug Discovery, by Therapeutic area USD Million (2017-2022)
  • Table 73. Taiwan Artificial Intelligence in Drug Discovery, by Functionality USD Million (2017-2022)
  • Table 74. Taiwan Artificial Intelligence in Drug Discovery, by Offering USD Million (2017-2022)
  • Table 75. Taiwan Artificial Intelligence in Drug Discovery, by End User USD Million (2017-2022)
  • Table 76. Australia Artificial Intelligence in Drug Discovery, by Application USD Million (2017-2022)
  • Table 77. Australia Artificial Intelligence in Drug Discovery, by Therapeutic area USD Million (2017-2022)
  • Table 78. Australia Artificial Intelligence in Drug Discovery, by Functionality USD Million (2017-2022)
  • Table 79. Australia Artificial Intelligence in Drug Discovery, by Offering USD Million (2017-2022)
  • Table 80. Australia Artificial Intelligence in Drug Discovery, by End User USD Million (2017-2022)
  • Table 81. Rest of Asia-Pacific Artificial Intelligence in Drug Discovery, by Application USD Million (2017-2022)
  • Table 82. Rest of Asia-Pacific Artificial Intelligence in Drug Discovery, by Therapeutic area USD Million (2017-2022)
  • Table 83. Rest of Asia-Pacific Artificial Intelligence in Drug Discovery, by Functionality USD Million (2017-2022)
  • Table 84. Rest of Asia-Pacific Artificial Intelligence in Drug Discovery, by Offering USD Million (2017-2022)
  • Table 85. Rest of Asia-Pacific Artificial Intelligence in Drug Discovery, by End User USD Million (2017-2022)
  • Table 86. Europe Artificial Intelligence in Drug Discovery, by Country USD Million (2017-2022)
  • Table 87. Europe Artificial Intelligence in Drug Discovery, by Application USD Million (2017-2022)
  • Table 88. Europe Artificial Intelligence in Drug Discovery, by Therapeutic area USD Million (2017-2022)
  • Table 89. Europe Artificial Intelligence in Drug Discovery, by Functionality USD Million (2017-2022)
  • Table 90. Europe Artificial Intelligence in Drug Discovery, by Offering USD Million (2017-2022)
  • Table 91. Europe Artificial Intelligence in Drug Discovery, by End User USD Million (2017-2022)
  • Table 92. Germany Artificial Intelligence in Drug Discovery, by Application USD Million (2017-2022)
  • Table 93. Germany Artificial Intelligence in Drug Discovery, by Therapeutic area USD Million (2017-2022)
  • Table 94. Germany Artificial Intelligence in Drug Discovery, by Functionality USD Million (2017-2022)
  • Table 95. Germany Artificial Intelligence in Drug Discovery, by Offering USD Million (2017-2022)
  • Table 96. Germany Artificial Intelligence in Drug Discovery, by End User USD Million (2017-2022)
  • Table 97. France Artificial Intelligence in Drug Discovery, by Application USD Million (2017-2022)
  • Table 98. France Artificial Intelligence in Drug Discovery, by Therapeutic area USD Million (2017-2022)
  • Table 99. France Artificial Intelligence in Drug Discovery, by Functionality USD Million (2017-2022)
  • Table 100. France Artificial Intelligence in Drug Discovery, by Offering USD Million (2017-2022)
  • Table 101. France Artificial Intelligence in Drug Discovery, by End User USD Million (2017-2022)
  • Table 102. Italy Artificial Intelligence in Drug Discovery, by Application USD Million (2017-2022)
  • Table 103. Italy Artificial Intelligence in Drug Discovery, by Therapeutic area USD Million (2017-2022)
  • Table 104. Italy Artificial Intelligence in Drug Discovery, by Functionality USD Million (2017-2022)
  • Table 105. Italy Artificial Intelligence in Drug Discovery, by Offering USD Million (2017-2022)
  • Table 106. Italy Artificial Intelligence in Drug Discovery, by End User USD Million (2017-2022)
  • Table 107. United Kingdom Artificial Intelligence in Drug Discovery, by Application USD Million (2017-2022)
  • Table 108. United Kingdom Artificial Intelligence in Drug Discovery, by Therapeutic area USD Million (2017-2022)
  • Table 109. United Kingdom Artificial Intelligence in Drug Discovery, by Functionality USD Million (2017-2022)
  • Table 110. United Kingdom Artificial Intelligence in Drug Discovery, by Offering USD Million (2017-2022)
  • Table 111. United Kingdom Artificial Intelligence in Drug Discovery, by End User USD Million (2017-2022)
  • Table 112. Netherlands Artificial Intelligence in Drug Discovery, by Application USD Million (2017-2022)
  • Table 113. Netherlands Artificial Intelligence in Drug Discovery, by Therapeutic area USD Million (2017-2022)
  • Table 114. Netherlands Artificial Intelligence in Drug Discovery, by Functionality USD Million (2017-2022)
  • Table 115. Netherlands Artificial Intelligence in Drug Discovery, by Offering USD Million (2017-2022)
  • Table 116. Netherlands Artificial Intelligence in Drug Discovery, by End User USD Million (2017-2022)
  • Table 117. Rest of Europe Artificial Intelligence in Drug Discovery, by Application USD Million (2017-2022)
  • Table 118. Rest of Europe Artificial Intelligence in Drug Discovery, by Therapeutic area USD Million (2017-2022)
  • Table 119. Rest of Europe Artificial Intelligence in Drug Discovery, by Functionality USD Million (2017-2022)
  • Table 120. Rest of Europe Artificial Intelligence in Drug Discovery, by Offering USD Million (2017-2022)
  • Table 121. Rest of Europe Artificial Intelligence in Drug Discovery, by End User USD Million (2017-2022)
  • Table 122. MEA Artificial Intelligence in Drug Discovery, by Country USD Million (2017-2022)
  • Table 123. MEA Artificial Intelligence in Drug Discovery, by Application USD Million (2017-2022)
  • Table 124. MEA Artificial Intelligence in Drug Discovery, by Therapeutic area USD Million (2017-2022)
  • Table 125. MEA Artificial Intelligence in Drug Discovery, by Functionality USD Million (2017-2022)
  • Table 126. MEA Artificial Intelligence in Drug Discovery, by Offering USD Million (2017-2022)
  • Table 127. MEA Artificial Intelligence in Drug Discovery, by End User USD Million (2017-2022)
  • Table 128. Middle East Artificial Intelligence in Drug Discovery, by Application USD Million (2017-2022)
  • Table 129. Middle East Artificial Intelligence in Drug Discovery, by Therapeutic area USD Million (2017-2022)
  • Table 130. Middle East Artificial Intelligence in Drug Discovery, by Functionality USD Million (2017-2022)
  • Table 131. Middle East Artificial Intelligence in Drug Discovery, by Offering USD Million (2017-2022)
  • Table 132. Middle East Artificial Intelligence in Drug Discovery, by End User USD Million (2017-2022)
  • Table 133. Africa Artificial Intelligence in Drug Discovery, by Application USD Million (2017-2022)
  • Table 134. Africa Artificial Intelligence in Drug Discovery, by Therapeutic area USD Million (2017-2022)
  • Table 135. Africa Artificial Intelligence in Drug Discovery, by Functionality USD Million (2017-2022)
  • Table 136. Africa Artificial Intelligence in Drug Discovery, by Offering USD Million (2017-2022)
  • Table 137. Africa Artificial Intelligence in Drug Discovery, by End User USD Million (2017-2022)
  • Table 138. North America Artificial Intelligence in Drug Discovery, by Country USD Million (2017-2022)
  • Table 139. North America Artificial Intelligence in Drug Discovery, by Application USD Million (2017-2022)
  • Table 140. North America Artificial Intelligence in Drug Discovery, by Therapeutic area USD Million (2017-2022)
  • Table 141. North America Artificial Intelligence in Drug Discovery, by Functionality USD Million (2017-2022)
  • Table 142. North America Artificial Intelligence in Drug Discovery, by Offering USD Million (2017-2022)
  • Table 143. North America Artificial Intelligence in Drug Discovery, by End User USD Million (2017-2022)
  • Table 144. United States Artificial Intelligence in Drug Discovery, by Application USD Million (2017-2022)
  • Table 145. United States Artificial Intelligence in Drug Discovery, by Therapeutic area USD Million (2017-2022)
  • Table 146. United States Artificial Intelligence in Drug Discovery, by Functionality USD Million (2017-2022)
  • Table 147. United States Artificial Intelligence in Drug Discovery, by Offering USD Million (2017-2022)
  • Table 148. United States Artificial Intelligence in Drug Discovery, by End User USD Million (2017-2022)
  • Table 149. Canada Artificial Intelligence in Drug Discovery, by Application USD Million (2017-2022)
  • Table 150. Canada Artificial Intelligence in Drug Discovery, by Therapeutic area USD Million (2017-2022)
  • Table 151. Canada Artificial Intelligence in Drug Discovery, by Functionality USD Million (2017-2022)
  • Table 152. Canada Artificial Intelligence in Drug Discovery, by Offering USD Million (2017-2022)
  • Table 153. Canada Artificial Intelligence in Drug Discovery, by End User USD Million (2017-2022)
  • Table 154. Mexico Artificial Intelligence in Drug Discovery, by Application USD Million (2017-2022)
  • Table 155. Mexico Artificial Intelligence in Drug Discovery, by Therapeutic area USD Million (2017-2022)
  • Table 156. Mexico Artificial Intelligence in Drug Discovery, by Functionality USD Million (2017-2022)
  • Table 157. Mexico Artificial Intelligence in Drug Discovery, by Offering USD Million (2017-2022)
  • Table 158. Mexico Artificial Intelligence in Drug Discovery, by End User USD Million (2017-2022)
  • Table 159. Company Basic Information, Sales Area and Its Competitors
  • Table 160. Company Basic Information, Sales Area and Its Competitors
  • Table 161. Company Basic Information, Sales Area and Its Competitors
  • Table 162. Company Basic Information, Sales Area and Its Competitors
  • Table 163. Company Basic Information, Sales Area and Its Competitors
  • Table 164. Company Basic Information, Sales Area and Its Competitors
  • Table 165. Company Basic Information, Sales Area and Its Competitors
  • Table 166. Company Basic Information, Sales Area and Its Competitors
  • Table 167. Company Basic Information, Sales Area and Its Competitors
  • Table 168. Company Basic Information, Sales Area and Its Competitors
  • Table 169. Artificial Intelligence in Drug Discovery: by Application(USD Million)
  • Table 170. Artificial Intelligence in Drug Discovery Disease Identification/Diagnosis , by Region USD Million (2023-2028)
  • Table 171. Artificial Intelligence in Drug Discovery Digital Therapeutics / Personalized Treatment/Behavioral Modification , by Region USD Million (2023-2028)
  • Table 172. Artificial Intelligence in Drug Discovery Drug Discovery and Manufacturing , by Region USD Million (2023-2028)
  • Table 173. Artificial Intelligence in Drug Discovery Predictive Forecasting , by Region USD Million (2023-2028)
  • Table 174. Artificial Intelligence in Drug Discovery Clinical Trials , by Region USD Million (2023-2028)
  • Table 175. Artificial Intelligence in Drug Discovery: by Therapeutic area(USD Million)
  • Table 176. Artificial Intelligence in Drug Discovery Immuno-Oncology , by Region USD Million (2023-2028)
  • Table 177. Artificial Intelligence in Drug Discovery Neurodegenerative Diseases , by Region USD Million (2023-2028)
  • Table 178. Artificial Intelligence in Drug Discovery Cardiovascular Diseases , by Region USD Million (2023-2028)
  • Table 179. Artificial Intelligence in Drug Discovery Others , by Region USD Million (2023-2028)
  • Table 180. Artificial Intelligence in Drug Discovery: by Functionality(USD Million)
  • Table 181. Artificial Intelligence in Drug Discovery Generating novel drug candidates , by Region USD Million (2023-2028)
  • Table 182. Artificial Intelligence in Drug Discovery Understanding disease mechanisms , by Region USD Million (2023-2028)
  • Table 183. Artificial Intelligence in Drug Discovery Aggregating and synthesizing information , by Region USD Million (2023-2028)
  • Table 184. Artificial Intelligence in Drug Discovery: by Offering(USD Million)
  • Table 185. Artificial Intelligence in Drug Discovery Software , by Region USD Million (2023-2028)
  • Table 186. Artificial Intelligence in Drug Discovery Services , by Region USD Million (2023-2028)
  • Table 187. Artificial Intelligence in Drug Discovery: by End User(USD Million)
  • Table 188. Artificial Intelligence in Drug Discovery Pharmaceutical & Biotechnology Companies , by Region USD Million (2023-2028)
  • Table 189. Artificial Intelligence in Drug Discovery Contract Research Organizations , by Region USD Million (2023-2028)
  • Table 190. Artificial Intelligence in Drug Discovery Research Centers , by Region USD Million (2023-2028)
  • Table 191. Artificial Intelligence in Drug Discovery Academic & Government Institutes , by Region USD Million (2023-2028)
  • Table 192. South America Artificial Intelligence in Drug Discovery, by Country USD Million (2023-2028)
  • Table 193. South America Artificial Intelligence in Drug Discovery, by Application USD Million (2023-2028)
  • Table 194. South America Artificial Intelligence in Drug Discovery, by Therapeutic area USD Million (2023-2028)
  • Table 195. South America Artificial Intelligence in Drug Discovery, by Functionality USD Million (2023-2028)
  • Table 196. South America Artificial Intelligence in Drug Discovery, by Offering USD Million (2023-2028)
  • Table 197. South America Artificial Intelligence in Drug Discovery, by End User USD Million (2023-2028)
  • Table 198. Brazil Artificial Intelligence in Drug Discovery, by Application USD Million (2023-2028)
  • Table 199. Brazil Artificial Intelligence in Drug Discovery, by Therapeutic area USD Million (2023-2028)
  • Table 200. Brazil Artificial Intelligence in Drug Discovery, by Functionality USD Million (2023-2028)
  • Table 201. Brazil Artificial Intelligence in Drug Discovery, by Offering USD Million (2023-2028)
  • Table 202. Brazil Artificial Intelligence in Drug Discovery, by End User USD Million (2023-2028)
  • Table 203. Argentina Artificial Intelligence in Drug Discovery, by Application USD Million (2023-2028)
  • Table 204. Argentina Artificial Intelligence in Drug Discovery, by Therapeutic area USD Million (2023-2028)
  • Table 205. Argentina Artificial Intelligence in Drug Discovery, by Functionality USD Million (2023-2028)
  • Table 206. Argentina Artificial Intelligence in Drug Discovery, by Offering USD Million (2023-2028)
  • Table 207. Argentina Artificial Intelligence in Drug Discovery, by End User USD Million (2023-2028)
  • Table 208. Rest of South America Artificial Intelligence in Drug Discovery, by Application USD Million (2023-2028)
  • Table 209. Rest of South America Artificial Intelligence in Drug Discovery, by Therapeutic area USD Million (2023-2028)
  • Table 210. Rest of South America Artificial Intelligence in Drug Discovery, by Functionality USD Million (2023-2028)
  • Table 211. Rest of South America Artificial Intelligence in Drug Discovery, by Offering USD Million (2023-2028)
  • Table 212. Rest of South America Artificial Intelligence in Drug Discovery, by End User USD Million (2023-2028)
  • Table 213. Asia Pacific Artificial Intelligence in Drug Discovery, by Country USD Million (2023-2028)
  • Table 214. Asia Pacific Artificial Intelligence in Drug Discovery, by Application USD Million (2023-2028)
  • Table 215. Asia Pacific Artificial Intelligence in Drug Discovery, by Therapeutic area USD Million (2023-2028)
  • Table 216. Asia Pacific Artificial Intelligence in Drug Discovery, by Functionality USD Million (2023-2028)
  • Table 217. Asia Pacific Artificial Intelligence in Drug Discovery, by Offering USD Million (2023-2028)
  • Table 218. Asia Pacific Artificial Intelligence in Drug Discovery, by End User USD Million (2023-2028)
  • Table 219. China Artificial Intelligence in Drug Discovery, by Application USD Million (2023-2028)
  • Table 220. China Artificial Intelligence in Drug Discovery, by Therapeutic area USD Million (2023-2028)
  • Table 221. China Artificial Intelligence in Drug Discovery, by Functionality USD Million (2023-2028)
  • Table 222. China Artificial Intelligence in Drug Discovery, by Offering USD Million (2023-2028)
  • Table 223. China Artificial Intelligence in Drug Discovery, by End User USD Million (2023-2028)
  • Table 224. Japan Artificial Intelligence in Drug Discovery, by Application USD Million (2023-2028)
  • Table 225. Japan Artificial Intelligence in Drug Discovery, by Therapeutic area USD Million (2023-2028)
  • Table 226. Japan Artificial Intelligence in Drug Discovery, by Functionality USD Million (2023-2028)
  • Table 227. Japan Artificial Intelligence in Drug Discovery, by Offering USD Million (2023-2028)
  • Table 228. Japan Artificial Intelligence in Drug Discovery, by End User USD Million (2023-2028)
  • Table 229. India Artificial Intelligence in Drug Discovery, by Application USD Million (2023-2028)
  • Table 230. India Artificial Intelligence in Drug Discovery, by Therapeutic area USD Million (2023-2028)
  • Table 231. India Artificial Intelligence in Drug Discovery, by Functionality USD Million (2023-2028)
  • Table 232. India Artificial Intelligence in Drug Discovery, by Offering USD Million (2023-2028)
  • Table 233. India Artificial Intelligence in Drug Discovery, by End User USD Million (2023-2028)
  • Table 234. South Korea Artificial Intelligence in Drug Discovery, by Application USD Million (2023-2028)
  • Table 235. South Korea Artificial Intelligence in Drug Discovery, by Therapeutic area USD Million (2023-2028)
  • Table 236. South Korea Artificial Intelligence in Drug Discovery, by Functionality USD Million (2023-2028)
  • Table 237. South Korea Artificial Intelligence in Drug Discovery, by Offering USD Million (2023-2028)
  • Table 238. South Korea Artificial Intelligence in Drug Discovery, by End User USD Million (2023-2028)
  • Table 239. Taiwan Artificial Intelligence in Drug Discovery, by Application USD Million (2023-2028)
  • Table 240. Taiwan Artificial Intelligence in Drug Discovery, by Therapeutic area USD Million (2023-2028)
  • Table 241. Taiwan Artificial Intelligence in Drug Discovery, by Functionality USD Million (2023-2028)
  • Table 242. Taiwan Artificial Intelligence in Drug Discovery, by Offering USD Million (2023-2028)
  • Table 243. Taiwan Artificial Intelligence in Drug Discovery, by End User USD Million (2023-2028)
  • Table 244. Australia Artificial Intelligence in Drug Discovery, by Application USD Million (2023-2028)
  • Table 245. Australia Artificial Intelligence in Drug Discovery, by Therapeutic area USD Million (2023-2028)
  • Table 246. Australia Artificial Intelligence in Drug Discovery, by Functionality USD Million (2023-2028)
  • Table 247. Australia Artificial Intelligence in Drug Discovery, by Offering USD Million (2023-2028)
  • Table 248. Australia Artificial Intelligence in Drug Discovery, by End User USD Million (2023-2028)
  • Table 249. Rest of Asia-Pacific Artificial Intelligence in Drug Discovery, by Application USD Million (2023-2028)
  • Table 250. Rest of Asia-Pacific Artificial Intelligence in Drug Discovery, by Therapeutic area USD Million (2023-2028)
  • Table 251. Rest of Asia-Pacific Artificial Intelligence in Drug Discovery, by Functionality USD Million (2023-2028)
  • Table 252. Rest of Asia-Pacific Artificial Intelligence in Drug Discovery, by Offering USD Million (2023-2028)
  • Table 253. Rest of Asia-Pacific Artificial Intelligence in Drug Discovery, by End User USD Million (2023-2028)
  • Table 254. Europe Artificial Intelligence in Drug Discovery, by Country USD Million (2023-2028)
  • Table 255. Europe Artificial Intelligence in Drug Discovery, by Application USD Million (2023-2028)
  • Table 256. Europe Artificial Intelligence in Drug Discovery, by Therapeutic area USD Million (2023-2028)
  • Table 257. Europe Artificial Intelligence in Drug Discovery, by Functionality USD Million (2023-2028)
  • Table 258. Europe Artificial Intelligence in Drug Discovery, by Offering USD Million (2023-2028)
  • Table 259. Europe Artificial Intelligence in Drug Discovery, by End User USD Million (2023-2028)
  • Table 260. Germany Artificial Intelligence in Drug Discovery, by Application USD Million (2023-2028)
  • Table 261. Germany Artificial Intelligence in Drug Discovery, by Therapeutic area USD Million (2023-2028)
  • Table 262. Germany Artificial Intelligence in Drug Discovery, by Functionality USD Million (2023-2028)
  • Table 263. Germany Artificial Intelligence in Drug Discovery, by Offering USD Million (2023-2028)
  • Table 264. Germany Artificial Intelligence in Drug Discovery, by End User USD Million (2023-2028)
  • Table 265. France Artificial Intelligence in Drug Discovery, by Application USD Million (2023-2028)
  • Table 266. France Artificial Intelligence in Drug Discovery, by Therapeutic area USD Million (2023-2028)
  • Table 267. France Artificial Intelligence in Drug Discovery, by Functionality USD Million (2023-2028)
  • Table 268. France Artificial Intelligence in Drug Discovery, by Offering USD Million (2023-2028)
  • Table 269. France Artificial Intelligence in Drug Discovery, by End User USD Million (2023-2028)
  • Table 270. Italy Artificial Intelligence in Drug Discovery, by Application USD Million (2023-2028)
  • Table 271. Italy Artificial Intelligence in Drug Discovery, by Therapeutic area USD Million (2023-2028)
  • Table 272. Italy Artificial Intelligence in Drug Discovery, by Functionality USD Million (2023-2028)
  • Table 273. Italy Artificial Intelligence in Drug Discovery, by Offering USD Million (2023-2028)
  • Table 274. Italy Artificial Intelligence in Drug Discovery, by End User USD Million (2023-2028)
  • Table 275. United Kingdom Artificial Intelligence in Drug Discovery, by Application USD Million (2023-2028)
  • Table 276. United Kingdom Artificial Intelligence in Drug Discovery, by Therapeutic area USD Million (2023-2028)
  • Table 277. United Kingdom Artificial Intelligence in Drug Discovery, by Functionality USD Million (2023-2028)
  • Table 278. United Kingdom Artificial Intelligence in Drug Discovery, by Offering USD Million (2023-2028)
  • Table 279. United Kingdom Artificial Intelligence in Drug Discovery, by End User USD Million (2023-2028)
  • Table 280. Netherlands Artificial Intelligence in Drug Discovery, by Application USD Million (2023-2028)
  • Table 281. Netherlands Artificial Intelligence in Drug Discovery, by Therapeutic area USD Million (2023-2028)
  • Table 282. Netherlands Artificial Intelligence in Drug Discovery, by Functionality USD Million (2023-2028)
  • Table 283. Netherlands Artificial Intelligence in Drug Discovery, by Offering USD Million (2023-2028)
  • Table 284. Netherlands Artificial Intelligence in Drug Discovery, by End User USD Million (2023-2028)
  • Table 285. Rest of Europe Artificial Intelligence in Drug Discovery, by Application USD Million (2023-2028)
  • Table 286. Rest of Europe Artificial Intelligence in Drug Discovery, by Therapeutic area USD Million (2023-2028)
  • Table 287. Rest of Europe Artificial Intelligence in Drug Discovery, by Functionality USD Million (2023-2028)
  • Table 288. Rest of Europe Artificial Intelligence in Drug Discovery, by Offering USD Million (2023-2028)
  • Table 289. Rest of Europe Artificial Intelligence in Drug Discovery, by End User USD Million (2023-2028)
  • Table 290. MEA Artificial Intelligence in Drug Discovery, by Country USD Million (2023-2028)
  • Table 291. MEA Artificial Intelligence in Drug Discovery, by Application USD Million (2023-2028)
  • Table 292. MEA Artificial Intelligence in Drug Discovery, by Therapeutic area USD Million (2023-2028)
  • Table 293. MEA Artificial Intelligence in Drug Discovery, by Functionality USD Million (2023-2028)
  • Table 294. MEA Artificial Intelligence in Drug Discovery, by Offering USD Million (2023-2028)
  • Table 295. MEA Artificial Intelligence in Drug Discovery, by End User USD Million (2023-2028)
  • Table 296. Middle East Artificial Intelligence in Drug Discovery, by Application USD Million (2023-2028)
  • Table 297. Middle East Artificial Intelligence in Drug Discovery, by Therapeutic area USD Million (2023-2028)
  • Table 298. Middle East Artificial Intelligence in Drug Discovery, by Functionality USD Million (2023-2028)
  • Table 299. Middle East Artificial Intelligence in Drug Discovery, by Offering USD Million (2023-2028)
  • Table 300. Middle East Artificial Intelligence in Drug Discovery, by End User USD Million (2023-2028)
  • Table 301. Africa Artificial Intelligence in Drug Discovery, by Application USD Million (2023-2028)
  • Table 302. Africa Artificial Intelligence in Drug Discovery, by Therapeutic area USD Million (2023-2028)
  • Table 303. Africa Artificial Intelligence in Drug Discovery, by Functionality USD Million (2023-2028)
  • Table 304. Africa Artificial Intelligence in Drug Discovery, by Offering USD Million (2023-2028)
  • Table 305. Africa Artificial Intelligence in Drug Discovery, by End User USD Million (2023-2028)
  • Table 306. North America Artificial Intelligence in Drug Discovery, by Country USD Million (2023-2028)
  • Table 307. North America Artificial Intelligence in Drug Discovery, by Application USD Million (2023-2028)
  • Table 308. North America Artificial Intelligence in Drug Discovery, by Therapeutic area USD Million (2023-2028)
  • Table 309. North America Artificial Intelligence in Drug Discovery, by Functionality USD Million (2023-2028)
  • Table 310. North America Artificial Intelligence in Drug Discovery, by Offering USD Million (2023-2028)
  • Table 311. North America Artificial Intelligence in Drug Discovery, by End User USD Million (2023-2028)
  • Table 312. United States Artificial Intelligence in Drug Discovery, by Application USD Million (2023-2028)
  • Table 313. United States Artificial Intelligence in Drug Discovery, by Therapeutic area USD Million (2023-2028)
  • Table 314. United States Artificial Intelligence in Drug Discovery, by Functionality USD Million (2023-2028)
  • Table 315. United States Artificial Intelligence in Drug Discovery, by Offering USD Million (2023-2028)
  • Table 316. United States Artificial Intelligence in Drug Discovery, by End User USD Million (2023-2028)
  • Table 317. Canada Artificial Intelligence in Drug Discovery, by Application USD Million (2023-2028)
  • Table 318. Canada Artificial Intelligence in Drug Discovery, by Therapeutic area USD Million (2023-2028)
  • Table 319. Canada Artificial Intelligence in Drug Discovery, by Functionality USD Million (2023-2028)
  • Table 320. Canada Artificial Intelligence in Drug Discovery, by Offering USD Million (2023-2028)
  • Table 321. Canada Artificial Intelligence in Drug Discovery, by End User USD Million (2023-2028)
  • Table 322. Mexico Artificial Intelligence in Drug Discovery, by Application USD Million (2023-2028)
  • Table 323. Mexico Artificial Intelligence in Drug Discovery, by Therapeutic area USD Million (2023-2028)
  • Table 324. Mexico Artificial Intelligence in Drug Discovery, by Functionality USD Million (2023-2028)
  • Table 325. Mexico Artificial Intelligence in Drug Discovery, by Offering USD Million (2023-2028)
  • Table 326. Mexico Artificial Intelligence in Drug Discovery, by End User USD Million (2023-2028)
  • Table 327. Research Programs/Design for This Report
  • Table 328. Key Data Information from Secondary Sources
  • Table 329. Key Data Information from Primary Sources
List of Figures
  • Figure 1. Porters Five Forces
  • Figure 2. Supply/Value Chain
  • Figure 3. PESTEL analysis
  • Figure 4. Global Artificial Intelligence in Drug Discovery: by Application USD Million (2017-2022)
  • Figure 5. Global Artificial Intelligence in Drug Discovery: by Therapeutic area USD Million (2017-2022)
  • Figure 6. Global Artificial Intelligence in Drug Discovery: by Functionality USD Million (2017-2022)
  • Figure 7. Global Artificial Intelligence in Drug Discovery: by Offering USD Million (2017-2022)
  • Figure 8. Global Artificial Intelligence in Drug Discovery: by End User USD Million (2017-2022)
  • Figure 9. South America Artificial Intelligence in Drug Discovery Share (%), by Country
  • Figure 10. Asia Pacific Artificial Intelligence in Drug Discovery Share (%), by Country
  • Figure 11. Europe Artificial Intelligence in Drug Discovery Share (%), by Country
  • Figure 12. MEA Artificial Intelligence in Drug Discovery Share (%), by Country
  • Figure 13. North America Artificial Intelligence in Drug Discovery Share (%), by Country
  • Figure 14. Global Artificial Intelligence in Drug Discovery share by Players 2022 (%)
  • Figure 15. Global Artificial Intelligence in Drug Discovery share by Players (Top 3) 2022(%)
  • Figure 16. Global Artificial Intelligence in Drug Discovery share by Players (Top 5) 2022(%)
  • Figure 17. BCG Matrix for key Companies
  • Figure 18. IBM Corporation (United States) Revenue, Net Income and Gross profit
  • Figure 19. IBM Corporation (United States) Revenue: by Geography 2022
  • Figure 20. Microsoft Corporation (United States) Revenue, Net Income and Gross profit
  • Figure 21. Microsoft Corporation (United States) Revenue: by Geography 2022
  • Figure 22. Google LLC (United States) Revenue, Net Income and Gross profit
  • Figure 23. Google LLC (United States) Revenue: by Geography 2022
  • Figure 24. NVIDIA Corporation (United States) Revenue, Net Income and Gross profit
  • Figure 25. NVIDIA Corporation (United States) Revenue: by Geography 2022
  • Figure 26. Atomwise, Inc. (United States) Revenue, Net Income and Gross profit
  • Figure 27. Atomwise, Inc. (United States) Revenue: by Geography 2022
  • Figure 28. Deep Genomics (Canada) Revenue, Net Income and Gross profit
  • Figure 29. Deep Genomics (Canada) Revenue: by Geography 2022
  • Figure 30. Cloud Pharmaceuticals, Inc. (United States) Revenue, Net Income and Gross profit
  • Figure 31. Cloud Pharmaceuticals, Inc. (United States) Revenue: by Geography 2022
  • Figure 32. Insilico Medicine (United States) Revenue, Net Income and Gross profit
  • Figure 33. Insilico Medicine (United States) Revenue: by Geography 2022
  • Figure 34. BenevolentAI Limited (United Kingdom) Revenue, Net Income and Gross profit
  • Figure 35. BenevolentAI Limited (United Kingdom) Revenue: by Geography 2022
  • Figure 36. Exscientia Limited (United Kingdom) Revenue, Net Income and Gross profit
  • Figure 37. Exscientia Limited (United Kingdom) Revenue: by Geography 2022
  • Figure 38. Global Artificial Intelligence in Drug Discovery: by Application USD Million (2023-2028)
  • Figure 39. Global Artificial Intelligence in Drug Discovery: by Therapeutic area USD Million (2023-2028)
  • Figure 40. Global Artificial Intelligence in Drug Discovery: by Functionality USD Million (2023-2028)
  • Figure 41. Global Artificial Intelligence in Drug Discovery: by Offering USD Million (2023-2028)
  • Figure 42. Global Artificial Intelligence in Drug Discovery: by End User USD Million (2023-2028)
  • Figure 43. South America Artificial Intelligence in Drug Discovery Share (%), by Country
  • Figure 44. Asia Pacific Artificial Intelligence in Drug Discovery Share (%), by Country
  • Figure 45. Europe Artificial Intelligence in Drug Discovery Share (%), by Country
  • Figure 46. MEA Artificial Intelligence in Drug Discovery Share (%), by Country
  • Figure 47. North America Artificial Intelligence in Drug Discovery Share (%), by Country
List of companies from research coverage that are profiled in the study
  • IBM Corporation (United States)
  • Microsoft Corporation (United States)
  • Google LLC (United States)
  • NVIDIA Corporation (United States)
  • Atomwise, Inc. (United States)
  • Deep Genomics (Canada)
  • Cloud Pharmaceuticals, Inc. (United States)
  • Insilico Medicine (United States)
  • BenevolentAI Limited (United Kingdom)
  • Exscientia Limited (United Kingdom)
Select User Access Type

Key Highlights of Report


Apr 2023 232 Pages 81 Tables Base Year: 2022 Coverage: 15+ Companies; 18 Countries

Request Sample Pages

Budget constraints? Get in touch with us for special pricing


Check Discount Now
Global Artificial Intelligence in Drug Discovery Quantitative research analysis
Global Artificial Intelligence in Drug Discovery Qualitative Industry Analysis
DOWNLOAD SAMPLE PDF

Talk to Our Experts

Want to Customize Study?


"We employ Market statistics, Industry benchmarking, Patent analysis, and Technological Insights to derive requirements and provide customize scope of work."

Make an Enquiry Now

Frequently Asked Questions (FAQ):

"The surge in cross-industry collaborations and partnerships to boost drug discovery drives the growth of the global artificial intelligence for the drug discovery and development market " is seen as one of major growth factors of Artificial Intelligence in Drug Discovery Market in years to come.
The Study can be customized subject to feasibility and data availability. Please connect with our sales representative for further information.
The Artificial Intelligence in Drug Discovery market study includes a random mix of players, including both market leaders and some top growing emerging players. Connect with our sales executive to get a complete of companies available in our research coverage.

Know More About Global Artificial Intelligence in Drug Discovery Report?

Have a Query? Click Here

Other Related Reports

Clinical Urine Testing Comprehensive Study by Type (Dipsticks, Pregnancy & Fertility Kits, Reagents, Disposables, PoC Analyzers), Application (UTI, Diabetes, Pregnancy, Others), End-users (Hospitals,...
$ 3450
Cardiac Ablation Technology Comprehensive Study by Type (Radiofrequency (RF) Ablators, Electrical Ablators, Cryoablation Devices, Ultrasound Ablators, Microwave Ablators), Application (Cardiac Rhythm...
$ 3750
Digital Operating Room Comprehensive Study by Application (Cardiovascular applications, Neurosurgical applications, Thoracic applications, Orthopedic applications, Other applications), End-users (Hos...
$ 3750
Veterinary Radiology Software Comprehensive Study by Application (Veterinary Clinics and Hospitals, Reference Labs, Other End-User), Animal (Companion Animals, Large Animals, Other Animals), Deploym...
$ 3350
E- Prescribing Solutions Comprehensive Study by Type (Integrated Solutions, Standalone Solutions), Application (Hospitals, Office-Based Physicians, Pharmacies), Components (Solutions, Services), Plat...
$ 3650
Online Healthcare Technology Comprehensive Study by Type (Telehealth, Cloud Computing, Artificial Intelligence, Healthcare Analytics, Revenue Cycle Management (RCM), Picture Archiving and Communicati...
$ 3750